Details, Fiction and who makes copyright semaglutide
In March 2025, the company announced new programs for a direct-to-customer supplying of its Wegovy weight loss drug. The company set up a brand new pharmacy, referred to as NovoCare, which might demand consumers $499 monthly for use of the drug, less than fifty percent the expense of the drug via other pharmaceutical distribution networks.[53]Other